Citigroup began coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) in a research note released on Wednesday morning, MarketBeat.com reports. The brokerage issued a buy rating on the biopharmaceutical company’s stock. AGIO has been the subject of a number of other research reports. Royal Bank Of Canada cut shares of Agios Pharmaceuticals from [...]
Agios Pharmaceuticals (NASDAQ:AGIO) Earns Buy Rating from Analysts at Citigroup
